2-SITE ELISA FOR QUANTIFICATION OF THE TERMINAL C5B-9 COMPLEMENT COMPLEX IN PLASMA - USE OF MONOCLONAL AND POLYCLONAL ANTIBODIES AGAINST A NEOANTIGEN OF THE COMPLEX
A. Accardopalumbo et al., 2-SITE ELISA FOR QUANTIFICATION OF THE TERMINAL C5B-9 COMPLEMENT COMPLEX IN PLASMA - USE OF MONOCLONAL AND POLYCLONAL ANTIBODIES AGAINST A NEOANTIGEN OF THE COMPLEX, Journal of immunological methods, 163(2), 1993, pp. 169-172
A quantitative ELISA procedure using monoclonal and polyclonal antibod
ies against neoantigens of the terminal C5b-9 complement complex has b
een developed. The ELISA was demonstrated to be both sensitive and rep
roducible. The normal range for C5b-9 determinations, defined as 2.5-9
7.5% interval of the values obtained in 76 healthy blood donors, was 3
.12-10.3 AU/ml. The presence of rheumatoid factor did not affect the d
etermination of C5b-9 as demonstrated by immunoabsorption studies.